QubeHealth-Pay, an Indian company building financial infrastructure for healthcare, announced its expansion into the Middle East and North Africa on September 11, 2026, with the launch of Qube FinTech & AI MENA Limited, a newly licensed entity based in Dubai’s International Financial Centre (DIFC).
Why it matters: This is QubePay’s first market outside India, and it’s entering with a meaningfully different business model than the consumer app it runs at home — shifting from a direct-to-employee payments platform to enterprise infrastructure licensed to insurers, employers, and hospital networks. That shift matters because it’s a bet that the underlying problem — healthcare costs outpacing what insurance actually covers — is structurally similar across very different healthcare systems, even if the specific gaps (elective care in the UAE, everyday outpatient costs in Kenya and Nigeria) look different market to market.
Fast facts
- Company: QubeHealth-Pay (“QubePay”), healthcare financial infrastructure company based in India
- New entity: Qube FinTech & AI MENA Limited (“Qube MENA”), licensed in Dubai’s DIFC
- Role: regional headquarters for the Gulf Cooperation Council (GCC) and North Africa
- Initial target markets: UAE, Egypt, Kenya, and Nigeria
- Business model in MENA: enterprise technology licensing to insurers, employers, hospital networks, and pharmaceutical companies — distinct from QubePay’s consumer payments platform in India
- India footprint: live across more than 300 corporates, reaching over 300,000 employee families, according to the company
Why MENA, why now
QubePay frames the expansion around a specific, worsening gap: healthcare costs across MENA are rising an estimated 8–12% annually, according to the company, outpacing both wage growth and, in many markets, government healthcare spending. That’s a company estimate rather than a figure drawn from a cited third-party source, and it’s worth treating it as directional rather than precise until confirmed independently.
Even in the UAE, one of the region’s more comprehensively insured markets, the company says large categories of care remain entirely self-funded: IVF and fertility treatment, dental implants, cosmetic and elective procedures, and wellness programs. Out-of-pocket spending runs considerably higher elsewhere in the region, particularly across parts of North and East Africa, where insurance penetration remains limited.
How Qube MENA differs from the India business
QubePay’s India platform is a consumer-facing payments and cashback app. Qube MENA is structured differently: rather than selling directly to individual patients or employees, it licenses purpose-built technology to enterprise participants — insurers, employers, hospital networks, and pharmaceutical companies — to solve financial problems within the healthcare sector.
Its stated capabilities include digital healthcare expense processing, claims facilitation and documentation, rule-based bill adjudication support, reconciliation infrastructure, and aggregated, consent-driven healthcare data and insights for insurers, employers, and healthcare brands. In effect, Qube is positioning itself as backend infrastructure for the region’s healthcare-payments system, rather than a product patients interact with directly.
Chris George, Co-Founder and Group CEO of QubePay, framed the shift as the same underlying problem showing up in different forms: “In the UAE, it’s the elective and non-insurable care that falls entirely outside insurance. In markets like Egypt, Kenya and Nigeria, it’s the everyday cost of pharmacy, diagnostics and outpatient care,” he said, describing the DIFC base as giving the company “a credible, regulated base to build the technology and data infrastructure insurers, employers and healthcare providers across the region need to manage this.”
The rollout plan across four markets
Qube’s initial regional focus spans the UAE, Egypt, Kenya, and Nigeria, with Dubai serving as the operating and regulatory base for all four. The company says each market will be entered differently, based on its specific regulatory and insurance landscape — combining partnerships with local insurers, healthcare providers, and financial institutions with selective technology-licensing arrangements rather than a single uniform playbook.
The company describes a phased approach: starting with regulatory engagement and partnership-building, moving into pilot deployments, and only then expanding into broader enterprise onboarding. No specific timeline was given for when any of the four markets would move from one phase to the next.
The data behind the expansion and its limits
One statistic in the announcement comes from an identifiable independent source: the Dubai Health Authority’s Health Accounts System (HASD) 2022 report, which put household out-of-pocket healthcare spending at approximately 10% of current health expenditure in Dubai — low by regional standards, largely because of mandatory health insurance. Notably, that figure excludes non-insurable elective categories like IVF, cosmetic, and dental procedures, which are paid for entirely out of pocket and aren’t captured in official OOP statistics — meaning even this government-sourced figure likely understates real out-of-pocket spending relative to what patients actually experience.
QubePay’s own announcement includes an unusually direct caveat worth preserving here: the company states its regional cost and market figures are drawn from its own research as of 2026 and “should be independently verified before reuse,” noting that national health-expenditure data is revised periodically. That’s a more transparent framing than most company announcements offer, and it’s worth taking at face value — treat the 8–12% regional cost-growth estimate and other company-sourced figures as QubePay’s own read of the market, not settled statistics.
Zoom out
QubePay’s expansion is a bet that healthcare-payments infrastructure — the unglamorous plumbing connecting insurers, employers, and providers — is a more scalable export than a consumer app would be, especially across markets with very different insurance systems and regulatory regimes. Whether phased, partnership-led entry into four structurally different markets at once proves manageable, or whether QubePay ends up concentrating on one or two of them first in practice, is the detail worth watching as pilots move toward actual enterprise deployments.
